Company intelligence / Profile preview

Tribun Health

Paris, Île-de-France, Francetribun.health ↗

Ownership: Private
Development stage: Commercial

Overview

Tribun Health has developed CaloPix®, an enterprise-grade digital pathology platform that leverages AI for cancer diagnosis and research. The company recently achieved FDA clearance for CaloPix®, enabling U.S. commercialization. The solution has been recognized multiple times as "Best in KLAS" for digital pathology. No clinical trial results are relevant as the company does not develop therapeutics.

Therapeutic areas: OncologyOther
Modalities: Device (software platform)Artificial intelligence (AI)Deep learning algorithms
Industry: Pathology

Beyond the preview

Go deeper on Tribun Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tribun Health.

Explore the full profile